We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWN icon
401
Northwest Natural Holdings
NWN
$2.18B
$7.39M 0.04%
+181,039
New +$7.07M
CMA
402
DELISTED
Comerica
CMA
$7.38M 0.04%
123,265
-34,286
-22% -$1.89M
WM icon
403
Waste Management
WM
$96.1B
$7.1M 0.03%
34,205
+1,701
+5% +$355K
CMI icon
404
Cummins
CMI
$88.5B
$7.08M 0.03%
21,871
-275
-1% -$81.5K
CTAS icon
405
Cintas
CTAS
$86B
$7.07M 0.03%
34,351
-353
-1% -$68.1K
PATH icon
406
UiPath
PATH
$6.32B
$7.07M 0.03%
552,463
-1,838,981
-77% -$22.5M
HLT icon
407
Hilton Worldwide
HLT
$72.6B
$7M 0.03%
30,386
+518
+2% +$112K
XLE icon
408
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$6.88M 0.03%
156,812
-21,802
-12% -$975K
MEDP icon
409
Medpace
MEDP
$15.9B
$6.76M 0.03%
20,245
-56,046
-73% -$21.3M
RNR icon
410
RenaissanceRe
RNR
$13.9B
$6.75M 0.03%
24,773
-1,944
-7% -$469K
TRGP icon
411
Targa Resources
TRGP
$56.2B
$6.74M 0.03%
45,536
-1,770
-4% -$249K
AER icon
412
AerCap
AER
$24.3B
$6.69M 0.03%
70,592
+8,805
+14% +$825K
IWO icon
413
iShares Russell 2000 Growth ETF
IWO
$14.4B
$6.66M 0.03%
23,439
+880
+4% +$241K
MPLX icon
414
MPLX
MPLX
$60.1B
$6.65M 0.03%
149,509
+10,000
+7% +$427K
PAYC icon
415
Paycom
PAYC
$7.54B
$6.63M 0.03%
39,776
+16,559
+71% +$2.65M
D icon
416
Dominion Energy
D
$62.1B
$6.52M 0.03%
112,818
+594
+0.5% +$32.5K
AMD icon
417
Advanced Micro Devices
AMD
$741B
$6.5M 0.03%
39,597
+954
+2% +$145K
SO icon
418
Southern Company
SO
$109B
$6.46M 0.03%
71,632
-4,405
-6% -$376K
REGN icon
419
Regeneron Pharmaceuticals
REGN
$72.9B
$6.41M 0.03%
6,095
-810
-12% -$901K
SYY icon
420
Sysco
SYY
$40.8B
$6.39M 0.03%
81,880
-224,838
-73% -$16.9M
PHM icon
421
Pultegroup
PHM
$25.7B
$6.37M 0.03%
44,374
-523
-1% -$66.5K
FAST icon
422
Fastenal
FAST
$55.2B
$6.3M 0.03%
176,352
-4,978
-3% -$169K
MCHP icon
423
Microchip Technology
MCHP
$41.1B
$6.25M 0.03%
77,799
-4,275
-5% -$353K
VLO icon
424
Valero Energy
VLO
$88.7B
$6.14M 0.03%
45,505
+134
+0.3% +$19.5K
DTM icon
425
DT Midstream
DTM
$14.1B
$6.09M 0.03%
77,472
-937
-1% -$69.9K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.